Risk Of Developing Liver Cancer After HCV Treatment

Thursday, May 2, 2013

EASL 2013 - Internet Symposium: Watch Advances in Chronic Hepatitis C Management and Treatment

ViralEd Presents
 
The 48th Annual EASL: Advances in Chronic Hepatitis C Management and Treatment
 

 

Today, ViralEd released a 2-hour Internet symposium reviewing key studies on chronic hepatitis C management and treatment presented at this years meeting.

Watch and listen to Mark Sulkowski, MD, K. Rajender Reddy, MD, Fred Poordad, MD and Nezam Afdhal, MD review and discuss the following topics:
 
Updates On Current Status Of HCV Therapy
 
Boceprevir And Telaprevir
 
Novel Therapies And Strategies With Interferon
 
What's In The Near Future?
More Triple Therapy
 
Introduction To Faldaprevir
 
Interferon Free, All Oral Regimens 
 
 
NO registration required!
Takes only a few moments to load 
 
ViralEd, LLC is a physician-owned and directed medical education company whose mission is to provide thought-provoking, effective, and evidence-based CME to help improve health care provider knowledge and professional development. For over a decade, ViralEd's team of dedicated professionals have specialized in using a blended learning approach that combines innovative technology with live programming to provide programs and medical education content that is unique and of high quality.
 

No comments:

Post a Comment